Integra LifeSciences Holdings CEO Peter Arduini's 2018 pay rises 7% to $7.6M
Integra LifeSciences Holdings reports 2018 executive compensation
By ExecPay News
Published: April 16, 2019
Integra LifeSciences Holdings reported fiscal year 2018 executive compensation information on April 16, 2019.
In 2018, six executives at Integra LifeSciences Holdings received on average a compensation package of $2.8M, a 8% increase compared to previous year.
Average pay of disclosed executives at Integra LifeSciences Holdings
Peter J. Arduini, Chief Executive Officer, received $7.6M in total, which increased by 7% compared to 2017. 50% of Arduini's compensation, or $3.8M, was in stock awards. Arduini also received $1.2M in non-equity incentive plan, $1.6M in option awards, $948K in salary, as well as $17K in other compensation.
For fiscal year 2018, the median employee pay was $73,170 at Integra LifeSciences Holdings. Therefore, the ratio of Peter J. Arduini's pay to the median employee pay was 105 to one.
Richard D. Gorelick, General Counsel, received a compensation package of $2.8M, which increased by 167% compared to previous year. 73% of the compensation package, or $2M, was in other compensation.
Glenn G. Coleman, Chief Financial Officer, earned $2.3M in 2018, which is about the same as previous year.
Daniel L. Reuvers, Corporate Vice President, President, Codman Surgical Solutions, received $1.8M in 2018, which increases by 43% compared to 2017.
Robert T. Davis, Jr, Corporate Vice President, President, Orthopedics and Tissue Technologies, earned $1.4M in 2018, a 5% decrease compared to previous year.
Eric I. Schwartz, General Counsel, received $1.1M in 2018.
Related executives
Peter Arduini
Integra LifeSciences Holdings
Chief Executive Officer
Glenn Coleman
Integra LifeSciences Holdings
Chief Operating Officer
Robert Davis
Integra LifeSciences Holdings
Executive Vice President, President, Tissue Technologies
Daniel Reuvers
Integra LifeSciences Holdings
Executive Vice President, President, Codman Surgical Solutions
Richard Gorelick
Integra LifeSciences Holdings
General Counsel
Eric Schwartz
Integra LifeSciences Holdings
Chief Legal Officer
You may also like
Source: SEC filing on April 16, 2019.